REQUEST A DEMO
Total
USD $0.00
Search more companies

Rubus Pharma S.R.O. (Czech Republic)

Main Activities: Wholesale Trade | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Rubus Pharma S.R.O. Profile Updated: August 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Rubus Pharma S.R.O. is based in Czech Republic, with the head office in Roznov pod Radhostem. The company operates in the Wholesale Trade sector. It was incorporated on October 14, 2013. There are currently 25 - 49 (2024) people employed by Rubus Pharma S.R.O.. The company’s latest financial report indicates a net sales revenue increase of 4.87% in 2025. Its’ total assets recorded a growth of 5.44%. The net profit margin of Rubus Pharma S.R.O. increased by 0.64% in 2025.

Headquarters
Partyzanska 1007
Roznov pod Radhostem; Zlinsky; Postal Code: 75661

Contact Details: Purchase the Rubus Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Rubus Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Rubus Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Rubus Pharma S.R.O. report to view the information.
Incorporation Date:
October 14, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Rubus Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
4.87%
Total Operating Revenue
4.93%
Operating Profit
40.37%
EBITDA
20.48%
Net Profit/Loss for the Period
53.59%
Total Assets
5.44%
Total Equity
19.68%
Operating Profit Margin
0.78%
Net Profit Margin
0.64%
Return on Equity (ROE)
3.63%
Quick Ratio
0.21%
Cash Ratio
0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?